ORIC Pharmaceuticals Inc
ORIC
Market Cap$920.42M
Close$
$0.81
92.3% downside
Current Fair Value
92.3% downsideOvervalued by 92.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $920.42 Million |
|---|---|
| Enterprise Value | $871.09 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.83 |
| Beta | 1.48 |
| Outstanding Shares | 71,040,580 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.77 |
|---|---|
| PEG | -28.83 |
| Price to Sales | - |
| Price to Book Ratio | 3.48 |
| Enterprise Value to Revenue | 1634.31 |
| Enterprise Value to EBIT | -5.93 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About ORIC Pharmaceuticals Inc
CEO: Jacob Chacko